Klaus Breiner

Experience

1. Pureos Partners AGCo-founder and Managing Directorcurrent2021 — presentFreienbach, Schwyz, Switzerland
2. VICO Therapeutics B.V.Non-executive Directorcurrent2021 — presentLeiden, South Holland, Netherlands
3. Pureos BioventuresManaging Partnercurrent2017 — presentPfäffikon, Schwyz, Switzerland
4. BB Biotech VenturesPartnercurrent2004 — presentZurich, Switzerland
5. Vaximm AGCo-Founder & Vice-Chairman (Executive Chairman till mid-2016)2008 — 2022Basel, Basel, Switzerland
6. ORTHOCONBoard Director2006 — 2021Irvington, New York, United States
7. BellevueSenior Adviser Private Equity2004 — 2021Küsnacht, Zurich, Switzerland
8. Alpex Pharma SABoard Director2007 — 2020Mezzovico, TI, Switzerland
9. AM-PharmaBoard Director2011 — 2019
10. Pevion Biotech AGBoard Director2007 — 2011
11. Glycart Biotechnology AGBoard Director2003 — 2004Zurich, Switzerland
12. Global Life Science VenturesInvestment Manager2001 — 2004Greater Munich Metropolitan Area
13. Booz Allen HamiltonAssociate2000 — 2001
14. ETH ZurichPost-doctoral Fellow1999 — 2000
15. ZMBH - Universität HeidelbergPost-doctoral Fellow1998 — 1999
16. ZMBH - Universität HeidelbergResearch Associate1995 — 1998

Education

1. Heidelberg UniversityPh.D. (Dr.rer.nat.), Biochemistry and Molecular Biology1995 — 1998
2. The University of North Carolina at Chapel HillMaster of Arts (M.A.), Chemistry1994 — 1995
3. University of DüsseldorfChemistry1993 — 1994
4. FernUniversität in HagenBusiness Administration & Economics1990 — 1994
5. FH Aachen University of Applied SciencesDiplom Ingenieur, Chemical Engineering1990 — 1993

Skills & more

From Klaus's professional profile.

Same school

Also attended Heidelberg University33

MSMojca SkoberneEntrepreneur in Residence at GV (Google Ventures)KYKeita Yazakiシニア・アソシエイト (Senior Associate) at CyberAgent CapitalFHFabian HeilemannFounder & CEO at AENUSPStella PaffenholzSenior Associate at Atlas VentureKTKeith TanHead of DeFi at CaladanSFSteffen FunckInvestment Director at Statkraft Ventures

+ 27 more

Also attended The University of North Carolina at Chapel Hill175

CMClint MyersInvestor at RevolutionMSMahati SridharPartner, Rise of the Rest at RevolutionEWEric WagnerVP of Research and Data at Redpoint VenturesSDSoul DayanInvestor at True VenturesALAlexander LimInvestor at IVP (Institutional Venture Partners)ATAlex TaubPrincipal at QED Investors

+ 169 more

Also attended University of Düsseldorf6

TSTheodor SchultePrincipal at EnBW New Ventures GmbHIFIsabella FandrychGeneral Partner at Nucleus CapitalAHAntje Hensel-RothChief People and External Affairs Officer at Intermediate Capital GroupPSPhilip StarkInvestor at Oyster Bay Venture CapitalDFDavid FinkenstädtPartner at Postera CapitalTCThibaut ChesséPartner at Sparkle Ventures

Also attended FernUniversität in Hagen13

WDWolfgang DenglerContact for financing questions at Bayern KapitalSASiyana AsenovaFinance Manager at Planet A VenturesLSLars SingbartlSenior Advisor & Chairman at BlockwallJCJohannes ClaussSerial Entrepreneur, Investor and Mentor at tokentus investment AGJKJanosch KühnInvestor at BLN CapitalAJAlexander JekatInvestment Analyst at Brandenburg Kapital

+ 7 more

Shared employers

Also worked at VICO Therapeutics B.V.3

FVFelice Verduyn - Van WeegenPartner at EQT Life SciencesITIshaan TewarieVice President at EQT Life SciencesSNSilvia NoimanVenture Partner at Pontifax Venture Capital

Also worked at Vaximm AG2

SVSten VerlandVenture Partner at Sunstone CapitalCZCheryl ZimberlinInvestor at M Ventures

Also worked at ORTHOCON1

JPJohn PacificoInvestor at Canaan Partners

Also worked at Global Life Science Ventures1

HRHolger ReithingerGeneral Partner at Forbion